Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males

NCT02781311 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02781311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02781311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2A Study of Setipiprant Tablets in Androgenetic Alopecia in Males
Lead sponsor
Allergan
Phase
Phase 2
Overall status
Completed
Start date
July 14, 2016
Completion date
May 22, 2018
Enrollment
169 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia